Dr. Rizvi Discusses Pembrolizumab for Non-Small Cell Lung Cancer

1 Views
administrator
administrator
07/14/23

Naiyer A. Rizvi, MD, an associate attending physician, Memorial Sloan Kettering Cancer Center, discusses pembrolizumab (MK-3475) for the treatment of non-small cell lung cancer (NSCLC).

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next